Press release
Drug Screening Market to Perceive Excellent CAGR of 17.3% by 2029, Emerging Trends, Development Status, Revenue and Opportunity Outlook
Drug Screening Market report gives an edge to compete and to outdo the competition. By understanding client's requirements precisely, this report brings together business and product information for the sustainable growth in the market. A team of multi-lingual analysts and project managers is right there who are skilled to serve clients on every strategic aspect including product development, key areas of development, application modelling, use of technologies, the acquisition strategies, exploring niche growth opportunities and new markets. The large scale Drug Screening Market research report estimates the growth rate and the market value based on market dynamics and growth inducing factors.Global drug screening market was valued at USD 5.3 billion in 2021 and is expected to reach USD 18.99 billion by 2029, registering a CAGR of 17.3% during the forecast period of 2022-2029. The "urine" accounts for the largest sample type segment in the drug screening market within the forecasted period owing to the benefits it offers such as cost-effectiveness, high detection accuracy of multiple drugs and instant results. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Drug screening test basically analyses biological samples including blood, hair and urine; to diagnose the presence of drug abuse or its metabolites in patient's body. Drug screening tests are used to determine whether or not a person is or was under the influence of drugs at any given time. Due to the introduction of new technology, providing users with precise and accurate results.
Global Drug Screening Market Dynamics
Drivers
• Rising Workplace Regulations for Employees
Stringent employment regulations and workplace policies necessitate routine drug testing, particularly in safety-sensitive industries such as transportation, construction, and healthcare. Employers must implement drug screening programs to adhere to legal requirements, ensuring a safe working environment and minimizing potential liabilities. This driver underscores the critical role of drug testing in maintaining workplace safety, employee well-being, and compliance with industry-specific standards.
• Rising Substance Abuse Issues
The escalating prevalence of substance abuse problems, including the opioid crisis, propels the demand for robust drug screening measures. Industries and healthcare organizations face the challenge of promptly identifying and addressing substance abuse to mitigate its impact on individual health and overall societal well-being. The urgent need to combat substance abuse-related issues positions drug screening as a crucial tool in early detection, intervention, and prevention, aligning with broader public health objectives and regulatory imperatives.
Some of the major players operating in the drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory Inc., (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), Sciteck, Inc. (US), Synens SAS (France), Intoximeters (US), AccuSource Inc., (US), Cordant Health Solutions (US), and Millennium Health (US) among others.
Global Drug Screening Market Scope
The drug screening market is segmented on the basis of product and services, sample type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
• Equipment
• Rapid Testing Devices (RTD)
• Consumables
• Laboratory Services
On the basis of product and services, the drug screening market is segmented into equipment, rapid testing devices (RTD), consumables and laboratory services. Equipment is further sub segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. Breath analyzers is further sub segmented into semiconductor breath analyzers and fuel cell analyzers. Rapid testing devices (RTD) is further sub segmented into oral fluid testing devices and urine testing devices. Consumables is further sub segmented into assay kits, calibrators and controls, and sample collection cups.
Sample Type
• Oral Fluid or Saliva
• Breath
• Hair
• Urine
• Other Samples
On the basis of sample type, the drug screening market is segmented into oral fluid or saliva, breath, hair, urine and other samples. Urine sample is projected to dominate the market owing to the benefits it offers such as cost-effectiveness, high detection accuracy of multiple drugs and instant results.
End User
• Workplace and Schools
• Criminal Justice Systems and Law Enforcement Agencies
• Drug Testing Laboratories
• Drug Treatment Centers
• Hospitals
• Personal Users
• Pain Management Centers
On the basis of end user, the drug screening market is bifurcated into workplace and schools, criminal justice systems and law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, personal users and pain management centers.
Browse a Detailed Summary of Research Report @ https://www.databridgemarketresearch.com/reports/global-drug-screening-market
It's in your best interest to take this report into consideration because:
• Strong and extensive research methods were used to construct this study. The thoroughness and precision of the market reports produced by Data Bridge Market Research have earned them a great reputation.
• A complete picture of the competitive scenario of the Drug Screening market is depicted by this report.
• The wide range of research on how these innovations may affect market expansion in the future.
• The report's findings are presented in an approachable format, with accompanying visuals (such as histograms, bar graphs, pie charts, etc.) that make the data readily digestible.
• The potential, threats, and difficulties in the Drug Screening market, as well as the factors driving and restraining it, are discussed at length.
• It gives an all-encompassing evaluation of the anticipated conduct of the future market and the changing market condition.
• This study provides a number of strategic business approaches to assist you in making educated business decisions.
Browse Related Reports
https://dbmrmarkett.blogspot.com/2023/12/automated-blood-collection-market.html
https://dbmrmarkett.blogspot.com/2023/12/healthcare-transportation-service.html
https://dbmrmarkett.blogspot.com/2023/12/medical-marijuana-market-size-share.html
https://dbmrmarkett.blogspot.com/2023/12/ambulatory-surgery-center-market.html
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Screening Market to Perceive Excellent CAGR of 17.3% by 2029, Emerging Trends, Development Status, Revenue and Opportunity Outlook here
News-ID: 3332353 • Views: …
More Releases from Data Bridge Market Research

Cardiovascular Prosthetic Devices Market Size Trends and Forecast by Application …
The pouches market has emerged as a dynamic and rapidly evolving segment within the packaging industry. With increasing demand for flexible, lightweight, and sustainable packaging solutions, pouches have become a preferred choice for a wide range of industries, including food and beverage, pharmaceuticals, personal care, and household products. This guest post delves into the overview, scope, market trends, and key factors driving the growth of the pouches market.
Full report :…

Pouches Market 2024-2040 Revolutionary Insights into Trends, Dynamics, Growth, F …
Overview of the Pouches Market
Pouches are flexible packaging solutions made from materials such as plastic, aluminum, and paper. They come in various forms, including stand-up pouches, flat pouches, spouted pouches, and zipper pouches. Their lightweight design, cost-effectiveness, and ability to extend product shelf life have made them a popular alternative to traditional rigid packaging like bottles and cans.
The global pouches market has witnessed significant growth in recent years, driven by…

Retinal Disease Therapeutics Market: A Comprehensive Overview
Introduction
Retinal diseases, including conditions like age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion, represent a major health concern worldwide. These diseases are leading causes of vision impairment and blindness, particularly among aging populations. The retinal disease therapeutics market encompasses the development, production, and distribution of drugs and treatments aimed at addressing these conditions. Therapeutic solutions can range from drug injections to laser therapies and surgical interventions, with a…

Cardiac Point of Care Testing Kits Market: An In-Depth Analysis
Introduction
Cardiac Point of Care Testing (POCT) kits are revolutionizing the way heart conditions are diagnosed and monitored. These diagnostic devices allow healthcare professionals to test patients' cardiac health quickly and efficiently at the point of care, such as in a doctor's office, emergency room, or even at home. Cardiac POCT kits are designed to detect key biomarkers that indicate heart conditions like myocardial infarction (heart attack), congestive heart failure, and…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…